Profile data is unavailable for this security.
About the company
Rekah Pharmaceutical Industry Ltd. (Rekah) is an Israel-based company which operates directly and through its subsidiaries. The Company operates two Good Manufacturing Practice (GMP) approved manufacturing sites, it has a marketing and distribution arm, a chain of pharmacies, and an export import unit. Rekah's plant covers approximately 5,000 square meters and was designed to take advantage of the most advanced and automated packaging techniques available. In April 1995, Rekah received the approval of the Ministry of Health for its new facility. The sterile department was designed to meet the standard of the United States Food and Drug Administration and was opened in February 1997. The Company distributes its products through Ophir & Shalpharm to institutional users such as Israel Health Funds, hospitals and government health facilities. Other subsidiaries include Vitamed Pharmaceutical Industry Ltd., CenterPharm, RITE, Talmor, BARBARA WOLF Ltd. and Madad.
- Revenue in ILS (TTM)300.24m
- Net income in ILS-14.11m
- Incorporated1993
- Employees434.00
- LocationRekah Pharmaceutical Industry Ltd30 Hamelach StreetHOLON 5881904IsraelISR
- Phone+972 35581233
- Fax+972 35565919
- Websitehttps://www.rekah.co.il/
| Holder | Shares | % Held |
|---|---|---|
| Yelin Lapidot Mutual Fund Management Ltd.as of 30 Nov 2025 | 30.80k | 0.27% |
| IBI Mutual Funds Management (1978) Ltd.as of 30 Nov 2025 | 18.34k | 0.16% |
| Meitav Mutual Funds Ltd.as of 30 Nov 2025 | 1.41k | 0.01% |
| KSM Mutual Funds Ltd.as of 30 Nov 2025 | 812.00 | 0.01% |
| Migdal Mutual Funds Ltd.as of 30 Nov 2025 | 489.00 | 0.00% |
| Psagot Mutual Funds Ltd.as of 30 Nov 2025 | 172.00 | 0.00% |
| Harel Mutual Funds Ltd.as of 30 Nov 2025 | 71.00 | 0.00% |
